[1]
Rahman, F., Ishrat, S., Halder, S., Nasrin, I. and Amir, M. 2022. Lisinopril, an angiotensin converting enzyme inhibitor for the treatment of idiopathic oligospermia: a randomized controlled trial. International Journal of Reproduction, Contraception, Obstetrics and Gynecology. 11, 10 (Sep. 2022), 2594–2599. DOI:https://doi.org/10.18203/2320-1770.ijrcog20222368.